Why Investors Need to Take Advantage of These 2 Medical Stocks Now — Positive
DXCM UNH Zacks Investment Research — February 04, 2026Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
MRVL T Zacks Investment Research — February 04, 2026Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now — Positive
AMAT LSCC Zacks Investment Research — February 04, 2026Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now — Positive
INCY VRTX Zacks Investment Research — February 04, 2026The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Investors Need to Take Advantage of These 2 Auto, Tires and Trucks Stocks Now — Positive
ALSN RIVN Zacks Investment Research — February 04, 2026The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
M2i Global, Volato Group partner Titanium X sends first titanium ore shipments to US — Positive
MTWO SOAR Proactive Investors — February 04, 2026M2i Global Inc (OTC:MTWO) and Volato Group announced that Titanium X has initiated its first shipment of titanium ore from Western Australia to the United States, marking an early step in their collaboration focused on developing critical mineral supply chains. The initial shipment consists of titanium ore samples sourced from both mineral sands and hard rock deposits.
Lumen Reports Better-Than-Expected Q4 Earnings, Revenues Down Y/Y — Positive
LUMN Zacks Investment Research — February 04, 2026LUMN beats Q4 earnings estimates as AI-driven fiber demand fuels $13B in PCF deals, while quarterly revenues decline year over year.
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings? — Neutral
CVS Zacks Investment Research — February 04, 2026CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
Electronic Arts Q3 Earnings and Revenues Increase Year Over Year — Negative
EA Zacks Investment Research — February 04, 2026EA posts year-over-year growth in fiscal Q3 earnings and revenues, even as higher operating costs pressure margins and operating income.
FirstService (FSV) Q4 Earnings and Revenues Surpass Estimates — Positive
FSV Zacks Investment Research — February 04, 2026FirstService (FSV) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.34 per share a year ago.
Williams to Report Q4 Earnings: What Surprise Awaits Investors? — Positive
WMB Zacks Investment Research — February 04, 2026WMB is set to report Q4 earnings on Feb. 10, with analysts expecting a 21% jump in profit and a 14% rise in revenues.
Should VNO Stock Be in Your Portfolio Ahead of Q4 Earnings? — Neutral
VNO Zacks Investment Research — February 04, 2026VNO heads into Q4 2025 earnings, with revenue and FFO declines expected, as intense competition in office markets pressures growth despite demand recovery.
New Toll Brothers Community, Birch Run at New Britain, is Now Open in Chalfont, Pennsylvania — Neutral
TOL GlobeNewsWire — February 04, 2026CHALFONT, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the opening of Birch Run at New Britain, a new luxury townhome community in Chalfont, Pennsylvania.
Tesla's $20B Capex & FSD/Robotaxi/Optimus Promises - Euphoria Continues — Negative
TSLA Seeking Alpha — February 04, 2026TSLA's hefty, multi-year capex guidance underscores its cash-heavy, infrastructure business, with it lending uncertainty to its euphoric stock prices/valuations. This is especially since the multi-faceted growth opportunities across EVs/robotaxi/Optimus/battery/lithium refinery/chip fab suggest its intermediate-term free cash flow and balance sheet risks. TSLA has also signaled the mixed Robotaxi and Optimus monetization prospects, with it uncertain when the 'quantum leap' in their mass production/commercialization may occur.
Clorox Q2 Earnings Miss Estimates, Lower Organic Sales Hurt — Negative
CLX Zacks Investment Research — February 04, 2026CLX posts mixed Q2 FY26 results as earnings miss estimates, sales decline year over year and ERP-related pressures weigh on performance.
Here's Why Home Depot's Pro Strategy Is a Long-Term Growth Lever — Positive
HD Zacks Investment Research — February 04, 2026HD deepens its Pro ecosystem with digital tools, supply-chain integration and cross-selling to win bigger Pro projects amid market headwinds.
Columbia Banking's 2026 Playbook After Pacific Premier Buyout — Neutral
COLB Zacks Investment Research — February 04, 2026A bigger Western footprint, rising core fees and a cleaner loan mix frame COLB's 2026 setup. NIM at 4%+, integration pace & capital returns round out the picture.
Coca-Cola's All-Weather Strategy: Built for Volatility or Peak Cycle? — Positive
KO Zacks Investment Research — February 04, 2026KO's all-weather strategy leans on marketing, innovation and portfolio strength to drive steady growth across cycles despite volatility.
Jimmy Choo Growth & Versace Sale Lift Capri Holdings' Q3 Earnings Beat — Positive
CPRI Zacks Investment Research — February 04, 2026CPRI beats Q3 estimates as Jimmy Choo grows and the Versace sale strengthens the balance sheet, lifting profits despite lower revenues.
AMD's Post-Earnings Dip Looks Like the Buying Window Bulls Wanted — Positive
AMD MarketBeat — February 04, 2026Advanced Micro Devices' NASDAQ: AMD share price dipped more than 5% following its Q4 2025 earnings report, opening a screaming buying opportunity because it missed the analysts' highest mark. Although results were better than the consensus, whisper numbers were pricing in gains that won't come until later this year, highlighting another issue with the report.
